SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Nath Bio-Genes (India) Ltd (NATHBIOGEN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537291 NSE: NATHBIOGEN Agriculture | Small Cap | Nath Bio-Genes Share Price

₹169.35 -4.55 (-2.62%)

As on 05-Jun'26 16:59

Nath Bio-Genes (India) Ltd (NATHBIOGEN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537291 NSE: NATHBIOGEN Agriculture | Small Cap | Nath Bio-Genes Share Price

₹169.35 -4.55 (-2.62%)

As on 05-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹330 Cr.
Current Price
₹169.4
52-Week Low / High
₹127 / 238
TTM EPS
₹23.4
TTM Sales
₹432 Cr.
Book Value per Share
₹362.8
P/E Ratio
7.44
Lower than its 5-year historical median
Industry PE
15.5
Price to Book (P/B)
0.48
Lower than its 5-year historical median
Price to Sales (P/S)
0.77
Lower than its 5-year historical median
EV/EBITDA
6.32
Lower than its 5-year historical median
Dividend Yield
1.37%
Profitability Efficiency
Return on Equity (ROE)
6.69%
Underperforms industry median
Return on Capital Employed (ROCE)
7.29%
Underperforms industry median
Return on Assets (ROA)
4.45%
Operating Profit Margin
14.7%
Net Profit Margin
11.63%
Gross Profit Margin
13.1%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
8.93%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
3.8%
Net Profit Growth (1 Year)
-
4.88%
Asset Quality
Promoter Holding
45.60%
Pledged shares (%) of Promoter's holding (%)
13.78%
Reserves
₹670 Cr.
Equity
₹19 Cr.
Face Value
₹10
All Time Low / High
₹38.90 / 585.00

Nath Bio-Genes (India) stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Nath Bio-Genes (India) Ltd a good quality company?
Nath Bio-Genes (India) Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Nath Bio-Genes (India) Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Nath Bio-Genes (India) Ltd vs industry peers?
Nath Bio-Genes (India) Ltd revenue CAGR is 5.30%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Nath Bio-Genes (India) Ltd?
Promoters hold 45.60% of the Nath Bio-Genes (India) Ltd, with 13.78% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Nath Bio-Genes (India) Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 7.1% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nath Bio-Genes (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ13.9%9.5%9.2%8.3%9.2%9.8%-7.8%7.1%7.3%7.3%-
Value Creation
Index ⓘ		0.0-0.3-0.3-0.4-0.3-0.3-1.6-0.5-0.5-0.5-

Growth Parameters ⓘ
Sales ⓘ162170192231280308278301333362432
Sales YoY Gr.-4.8%12.8%20.5%21.2%9.9%-9.5%8.2%10.4%8.9%-
Adj EPS ⓘ8.810.115.520.126.429.3-35.518.321.122.223.4
YoY Gr.-14.7%52.6%30%31.5%10.9%-221.2%NA15.2%5.3%-
BVPS (₹) ⓘ75.8189.5246.9267.1293.4322.7285.2301.7321.3341.3362.8
Adj Net
Profit ⓘ		14.116.229.438.250.255.7-67.534.940.242.344
Cash Flow from Ops. ⓘ-13.63.3-47-22.99.51.117.138.474.726.8-
Debt/CF from Ops. ⓘ-4.322.1-0.7-2.57.490.65.52.71.54.2-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ9.4%5.3%9.2%8.9%
Adj EPS ⓘ10.8%-3.4%NA5.3%
BVPSⓘ18.2%3.1%6.2%6.2%
Share Price 6.4% -16.6% -3.9% -11.6%

Key Financial Parameters ⓘ

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		12.47.67.67.89.49.5-11.76.36.86.76.6
Op. Profit
Mgn % ⓘ		15.217.121.118.819.621.813.416.315.214.814.3
Net Profit
Mgn % ⓘ		8.79.615.316.61818.1-24.211.612.111.710.3
Debt to
Equity ⓘ		0.50.20.10.10.10.20.20.20.20.20
Working Cap
Days ⓘ		490500520553552572652600577614771
Cash Conv.
Cycle ⓘ		262263264280271301360312297299403

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales162170192231280308278301333362
Operating Expenses ⓘ + 137141151188225241241252282310
Manufacturing Costs887088144181162129112139225
Material Costs-201210-25-41-13917-9-84
Employee Cost 14141216192425232730
Other Costs ⓘ 56454252676779100124139
Operating Profit ⓘ 25294043556737495052
Operating Profit Margin (%) 15.2%17.1%21.1%18.8%19.6%21.7%13.4%16.3%15.2%14.5%
Other Income ⓘ + 1112222115
Exceptional Items ⓘ 000000-89031
Interest ⓘ 610105791110910
Depreciation ⓘ 4311133334
Profit Before Tax ⓘ 151730394957-63364244
Tax ⓘ 1010-214122
Profit After Tax 141629385056-67354042
PAT Margin (%) 8.7%9.6%15.4%16.6%18.0%18.1%-24.2%11.7%12.1%11.6%
Adjusted EPS (₹)8.910.215.520.226.629.3-35.418.521.122.2
Dividend Payout Ratio (%)0%0%0%0%0%6.80%-5.60%10.80%9.50%9%

Valuation of Nath Bio-Genes - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 121303469508558613542573611649
Share Capital ⓘ 16161919191919191919
Reserves ⓘ 105287450489539594523554592630
Debt +58693258709992104107110
Long Term Debt152001011032
Short Term Debt43493257709992104104108
Minority Interest0000000000
Trade Payables48443750683543284279
Others Liabilities ⓘ 3938323234426387117180
Total Liabilities ⓘ 2664545706487297907407938771,017

Fixed Assets

Net Fixed Assets ⓘ +30207211232246247245244249250
Gross Block82224228250265267267270274279
Accumulated Depreciation52161718192022252529
CWIP ⓘ 0000000000
Investments ⓘ 5555555566
Inventories141130123155204226220208229331
Trade Receivables45528210810710986979489
Cash Equivalents 16452122294387688
Others Assets ⓘ 4354104126145173180200223253
Total Assets ⓘ 2664545706487297907407938771,017

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + -143-47-239117387527
PBT ⓘ 151730394957-63364244
Adjustment ⓘ 1013105710102131012
Changes in Working Capital ⓘ -39-26-87-64-45-65-19-1023-28
Tax Paid ⓘ -000-3-2-0-3-1-0-1
Cash Flow From Investing Activity ⓘ + -17-4-4-20-14-10-20-3-27-4
Capex -7-4-5-22-16-4-1-3-27-8
Net Investments -0-0-0-0-0-0-0-0-10
Others ⓘ -100021-7-19004
Cash Flow From Financing Activity ⓘ + 3059020616-22-2-10-11
Net Proceeds from Shares ⓘ 001360000000
Net Proceeds from Borrowing ⓘ 145-200-000-02-1
Interest Paid ⓘ -6-10-10-5-7-9-11-10-9-10
Dividend Paid ⓘ 000000-4-4-4-4
Others ⓘ 2210-17251225-81314
Net Cash Flow ⓘ -0539-2317-25343812

Financial Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)12.47.677.627.879.489.51-11.666.316.796.69
ROCE (%)13.859.59.28.289.249.78-7.827.117.347.29
Asset Turnover Ratio0.660.470.370.380.410.410.360.390.40.38
PAT to CFO Conversion(x)-10.19-1.62-0.610.180.02N/A1.091.880.64
Working Capital Days
Receivable Days101.50104.40127.50150.20140.20128.40127.80110.80105.1092.30
Inventory Days290.20291241.50220.30234.50255.50292.80259.40239.70282
Payable Days-905.301,361.901,554.10-634.40-528.40-1,4721,663.10744.30-1,432.10-262

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *16.3816.3816.3816.3816.3816.3813.7813.7813.7813.78
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nath Bio-Genes (India) Ltd FAQs

The current trading price of Nath Bio-Genes on 05-Jun-2026 16:59 is ₹169.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Jun-2026 the market cap of Nath Bio-Genes stood at ₹330.5 Cr

The latest P/E ratio of Nath Bio-Genes as of 04-Jun-2026 is 7.44.

The latest P/B ratio of Nath Bio-Genes as of 04-Jun-2026 is 0.48.

The 52-week high of Nath Bio-Genes is ₹238.0 and the 52-week low is ₹126.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nath Bio-Genes is ₹432 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Nath Bio-Genes (India) Ltd is a below average quality company.

The key valuation ratios of Nath Bio-Genes (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Nath Bio-Genes (India) Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Nath Bio-Genes (India) Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×